New Schizophrenia Treatment Shows Promise
Fujita Health University is investigating the efficacy of curcumin and sulforaphane as a new treatment for schizophrenia. A new drug, LB-102 (N-methyl amisulpride), has shown promise in treating acute schizophrenia during a 28-day double-blind trial. The study was published in JAMA Psychiatry.
Topics
Developing
- 907d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 907d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 907d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 907d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Source Alpha
Source Bravo
Source Charlie
Source Delta
Source Echo
Source Foxtrot
Source Golf
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade